Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00990899 · ClinicalTrials.gov registry record
Hypertension and Sleep Disordered Breathing in Pediatrics
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 24
- Enrollment target
NCT00990899: Completed study, sponsored by NYU Langone Health.
NCT00990899 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00990899 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The primary objective is to determine the prevalence of sleep disordered breathing in children with primary hypertension or pre hypertension. The secondary objectives are to determine any association factors for children with primary hypertension or prehypertension to have sleep disordered breathing be it gender, age, body mass index (BMI), family history (hx) or ethnic group.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-07 |
What the finished NCT00990899 record still lists
NCT00990899 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00990899 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00990899 about?
NCT00990899 is a clinical study titled "Hypertension and Sleep Disordered Breathing in Pediatrics". The primary objective is to determine the prevalence of sleep disordered breathing in children with primary hypertension or pre hypertension. The secondary objectives are to determine any association factors for children with primary hypertension or prehypertension to have sleep disordered breathing...
What is the current status of trial NCT00990899?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2008-10. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT00990899?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia